Conversely, in hepatocellular carcinoma, prostate cancer, and head/neck squamous cell carcinoma, DUSP1 exhibits significant downregulation as a tumor suppressor (Leelahavanichkul et al., 2014; Zhang et al., 2018; Du et al., 2020). Here, DUSP1 is linked to prostate carcinoma.